Erica Y Chung1, Jeremy Yardley. 1. The Warren Alpert Medical School of Brown University, Rhode Island Hospital/Hasbro Children's Hospital, Providence, Rhode Island, USA. echung@lifespan.org
Abstract
BACKGROUND: It has become common practice to empirically treat infants and children who have suspected gastroesophageal reflux disease by using acid-suppressive medications. However, evidence to support the effectiveness of these medications in the pediatric population is limited. With multiple studies in adult patients indicating increased risk of infection, we reviewed the literature to determine the association between acid-suppressive medications and serious adverse effects in infants and children. METHODS: We conducted a PubMed search on the adverse effects of H2 antagonists and proton pump inhibitors in pediatric patients. The studies selected were original research and systematic reviews with control groups and study objectives evaluating the relationship between acid-suppressive medications and serious adverse effects (namely, infections). RESULTS: Fourteen studies met our inclusion criteria. The majority of studies found a significant association between acid-suppressive medications and the risk of necrotizing enterocolitis, sepsis/bacteremia, pneumonia, and gastrointestinal infections in infants and children. CONCLUSIONS: Given the questionable efficacy of H2 antagonists and proton pump inhibitors and the growing evidence of increased risk of serious infections, acid-suppressive medications should be used cautiously in infants and children suspected of having gastroesophageal reflux disease.
BACKGROUND: It has become common practice to empirically treat infants and children who have suspected gastroesophageal reflux disease by using acid-suppressive medications. However, evidence to support the effectiveness of these medications in the pediatric population is limited. With multiple studies in adult patients indicating increased risk of infection, we reviewed the literature to determine the association between acid-suppressive medications and serious adverse effects in infants and children. METHODS: We conducted a PubMed search on the adverse effects of H2 antagonists and proton pump inhibitors in pediatric patients. The studies selected were original research and systematic reviews with control groups and study objectives evaluating the relationship between acid-suppressive medications and serious adverse effects (namely, infections). RESULTS: Fourteen studies met our inclusion criteria. The majority of studies found a significant association between acid-suppressive medications and the risk of necrotizing enterocolitis, sepsis/bacteremia, pneumonia, and gastrointestinal infections in infants and children. CONCLUSIONS: Given the questionable efficacy of H2 antagonists and proton pump inhibitors and the growing evidence of increased risk of serious infections, acid-suppressive medications should be used cautiously in infants and children suspected of having gastroesophageal reflux disease.
Authors: Daniel R Duncan; Janine Amirault; Paul D Mitchell; Kara Larson; Rachel L Rosen Journal: J Pediatr Gastroenterol Nutr Date: 2017-08 Impact factor: 2.839
Authors: Christopher A Gerdung; Adrian Tsang; Abdool S Yasseen; Kathleen Armstrong; Hugh J McMillan; Thomas Kovesi Journal: Lung Date: 2016-02-16 Impact factor: 2.584
Authors: Jeffrey Braithwaite; Peter D Hibbert; Adam Jaffe; Les White; Christopher T Cowell; Mark F Harris; William B Runciman; Andrew R Hallahan; Gavin Wheaton; Helena M Williams; Elisabeth Murphy; Charlotte J Molloy; Louise K Wiles; Shanthi Ramanathan; Gaston Arnolda; Hsuen P Ting; Tamara D Hooper; Natalie Szabo; John G Wakefield; Clifford F Hughes; Annette Schmiede; Chris Dalton; Sarah Dalton; Joanna Holt; Liam Donaldson; Ed Kelley; Richard Lilford; Peter Lachman; Stephen Muething Journal: JAMA Date: 2018-03-20 Impact factor: 56.272
Authors: Valentina Shakhnovich; P Brian Smith; Jeffrey T Guptill; Laura P James; David N Collier; Huali Wu; Chad E Livingston; Jian Zhao; Gregory L Kearns Journal: J Pediatr Date: 2018-02 Impact factor: 6.314
Authors: Mark A Underwood; Stephanie Gaerlan; Maria Lorna A De Leoz; Lauren Dimapasoc; Karen M Kalanetra; Danielle G Lemay; J Bruce German; David A Mills; Carlito B Lebrilla Journal: Pediatr Res Date: 2015-08-31 Impact factor: 3.756